Item 1.01. | Entry into a Material Definitive Agreement |
As previously reported, Xerox Corporation, Conduent Business Services, LLC (f/k/a Xerox Business Services, LLC), Conduent State Healthcare, LLC (f/k/a Xerox State Healthcare, LLC, f/k/a ACS State Healthcare, LLC) and Conduent Incorporated (the “Company” and, collectively with the other defendants identified above, the “Defendants”) have been a party to litigation with the State of Texas, via the Texas Office of Attorney General (the “State”) in the 53rd Judicial District Court of Travis County, Texas. On February 18, 2019, the Defendants entered into a Settlement Agreement and Release (“Agreement”) with the State and the Texas Health and Human Services Commission (the “HHSC”) that settles all claims alleged to have resulted from failures by the Defendants or Texas Medicaid & Healthcare Partnership to comply with obligations under two contracts between Conduent State Healthcare, LLC and the HHSC entered into in 2003 and 2010.
Pursuant to the terms of the Agreement the Company will pay the State $235,942,000 in full settlement of the claims asserted against the Defendants. This amount is payable in installments of: (1) $20,000,000 within 10 days of execution; (2) $20,000,000 by April 15, 2019; (3) $38,647,333.33 by July 31, 2019; (4) $78,647,333.33 by July 31, 2020; and (5) $78,647,333.33 by July 31, 2021. The Agreement does not prevent the Company from prepaying the foregoing amounts and the Company is currently considering whether to do so. The Company does not intend to make further disclosure regarding a possible prepayment unless it actually prepays such amounts in whole or in part. As part of the settlement, all proceedings in the lawsuit are suspended and the State and the HHSC will dismiss the lawsuit with prejudice and release the Defendants from all of the State’s claims after the settlement amount is paid in full. As of September 30, 2018, the Company had recorded a reserve of $110 million for this litigation. As a result of entering into the Agreement, the Company recorded an additional reserve of $113 million in the quarter ended December 31, 2018. The Defendants have not made any admission of liability or wrongdoing in entering into the Agreement.
A copy of the Agreement is filed as Exhibit 10.7(a) to this Current Report on Form8-K and is incorporated herein by reference. The description of the Agreement does not purport to be a complete description and is qualified in its entirety by reference to the full text of the Agreement. Additional information about the lawsuit can be found under the caption “Legal Proceedings” in the Company’s Quarterly Report on Form10-Q for the quarterly period ended September 30, 2018 as filed with the Securities and Exchange Commission on November 9, 2018.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.